Global Human HbA1c Reagent Test Kit Market Growth 2024-2030

Global Human HbA1c Reagent Test Kit Market Growth 2024-2030

Glycosylated hemoglobin (GHb) is formed by the slow non enzymatic binding of hemoglobin and glucose, which is irreversible. Its synthesis rate is directly proportional to the glucose concentration in the blood and lasts for 120 days of the lifespan of red blood cells. The level of GHb in the blood represents the average blood glucose level since 120 days. HbA1c, as a subtype of GHb, is a product of the N-terminal valine of the beta chain of red blood cell hemoglobin combined with glucose. It normally accounts for 60% to 70% of the total GHb, and its structure is stable. Therefore, HbA1c can reflect the average blood glucose level in the past three months. The value obtained from testing glycated hemoglobin every 2-3 months can serve as a complete objective indicator reflecting the blood glucose control status over the past few months. Therefore, unlike urine or blood glucose testing, HbA1c is not a value reflecting instantaneous blood glucose levels, but an average indicator reflecting glucose levels in recent months, and its value is not affected by short-term or occasional blood glucose fluctuations. The level of HbA1c has nothing to do with external factors such as blood drawing time, stress reaction, fasting, medication, etc., and the change of short-term lifestyle will not affect the detection results of HbA1c. It can accurately reflect the average blood sugar level of 2-3 months, and is a good monitoring indicator for the diagnosis, screening and treatment of diabetes.

The global Human HbA1c Reagent Test Kit market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Human HbA1c Reagent Test Kit Industry Forecast” looks at past sales and reviews total world Human HbA1c Reagent Test Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Human HbA1c Reagent Test Kit sales for 2024 through 2030. With Human HbA1c Reagent Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human HbA1c Reagent Test Kit industry.

This Insight Report provides a comprehensive analysis of the global Human HbA1c Reagent Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human HbA1c Reagent Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human HbA1c Reagent Test Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human HbA1c Reagent Test Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human HbA1c Reagent Test Kit.

United States market for Human HbA1c Reagent Test Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human HbA1c Reagent Test Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human HbA1c Reagent Test Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human HbA1c Reagent Test Kit players cover Abbott, Abcam(Danaher), Roche, Siemens Healthcare, NITTOBO MEDICAL, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human HbA1c Reagent Test Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Fluorescent Immune Chromatography Diagnostic Kit
Colorimetric Reagent Kit
Enzyme Linked Immunosorbent Assay Kit
Other

Segmentation by Application:
Diagnosis of Diabetes
Prediction of Chronic Complications of Diabetes
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Abcam(Danaher)
Roche
Siemens Healthcare
NITTOBO MEDICAL
Atlas Medical
Crystal Chem Inc
Randox
Labcorp
Beijing Strong Biotechnologies, Inc.
Zhejiang Orient Gene Biotech
Guangzhou DoChek Biotechnology
Guangdong Hecin Scientific, Inc.
Shanghai Chuanzhi BIO Technology
Beijing Baiao Leibo Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human HbA1c Reagent Test Kit market?

What factors are driving Human HbA1c Reagent Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human HbA1c Reagent Test Kit market opportunities vary by end market size?

How does Human HbA1c Reagent Test Kit break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.